Pub Date : 2026-02-03DOI: 10.1152/physrev.00001.2025
Ole Jensen, Mathilde Bonnefond
The alpha rhythm, first identified by Hans Berger 100 years ago, is the dominant non-invasive electrophysiological signature of the healthy human brain in the awake state. For decades, it was believed that the alpha rhythm reflected rest or idling; however, this perspective changed in the 2000s when researchers found that alpha oscillations increase with cognitive demands. This discovery led to a paradigm shift, demonstrating that alpha oscillations reflect the functional inhibition of brain regions that are not needed for a specific task, thereby directing information to task-specific areas. We have reviewed the physiological mechanisms involved in generating alpha oscillations, which has informed computational models explaining how these oscillations emerge within physiologically realistic networks. At the behavioural level, alpha oscillations are strongly modulated across nearly all cognitive paradigms tested in humans, reflecting the allocation of computational resources within the active brain network. Research in individuals with attention-related issues has highlighted their impaired ability to modulate alpha oscillations, which is associated with performance deficits. Therefore, further exploration of alpha oscillations has the potential to uncover causal mechanisms underlying attention problems, such as those related to ADHD and ageing. Lastly, advancements in technology are opening new avenues for characterising alpha oscillations in ecologically valid settings and across the lifespan. This progress sets the stage for exploring the role of alpha oscillations in cognitive development and their functioning in natural environments.
{"title":"The alpha rhythm: from physiology to behaviour.","authors":"Ole Jensen, Mathilde Bonnefond","doi":"10.1152/physrev.00001.2025","DOIUrl":"https://doi.org/10.1152/physrev.00001.2025","url":null,"abstract":"<p><p>The alpha rhythm, first identified by Hans Berger 100 years ago, is the dominant non-invasive electrophysiological signature of the healthy human brain in the awake state. For decades, it was believed that the alpha rhythm reflected rest or idling; however, this perspective changed in the 2000s when researchers found that alpha oscillations increase with cognitive demands. This discovery led to a paradigm shift, demonstrating that alpha oscillations reflect the functional inhibition of brain regions that are not needed for a specific task, thereby directing information to task-specific areas. We have reviewed the physiological mechanisms involved in generating alpha oscillations, which has informed computational models explaining how these oscillations emerge within physiologically realistic networks. At the behavioural level, alpha oscillations are strongly modulated across nearly all cognitive paradigms tested in humans, reflecting the allocation of computational resources within the active brain network. Research in individuals with attention-related issues has highlighted their impaired ability to modulate alpha oscillations, which is associated with performance deficits. Therefore, further exploration of alpha oscillations has the potential to uncover causal mechanisms underlying attention problems, such as those related to ADHD and ageing. Lastly, advancements in technology are opening new avenues for characterising alpha oscillations in ecologically valid settings and across the lifespan. This progress sets the stage for exploring the role of alpha oscillations in cognitive development and their functioning in natural environments.</p>","PeriodicalId":20193,"journal":{"name":"Physiological reviews","volume":" ","pages":""},"PeriodicalIF":28.7,"publicationDate":"2026-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146113941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-30DOI: 10.1152/physrev.00029.2025
Qiongzi Qiu,Mingyu Liang
The human genome harbors millions of non-coding sequence variants. Genome-wide association studies (GWAS) have identified thousands of robust associations linking non-coding variants to human physiological traits and complex diseases. Integrative approaches, including expression quantitative trait locus mapping, epigenomic profiling, and precise genome editing in trait-relevant cell types, enable the identification of effector genes and underlying regulatory mechanisms, such as long-range chromatin interactions, that mediate the effects of non-coding variants. Investigations of blood pressure (BP)-associated non-coding sequence variants have uncovered previously unrecognized roles of genes in BP regulation, reinforced the human genetic relevance of established BP regulatory pathways, and elucidated specific regulatory mechanisms by which non-coding variants influence gene expression and BP. Studies of orthologous non-coding genomic regions in animal models corresponding to human genomic regions harboring BP-associated variants have demonstrated substantial effects on BP, suggesting that the phenotypic impact of non-coding sequence variants may be large within human subgroups. Continued expansion of functional studies of trait-associated non-coding sequence variants, together with advances in mapping molecular quantitative trait loci and epigenomic landscapes, will provide novel insights directly relevant to human biology and disease and essential for understanding humans as molecular systems.
{"title":"Molecular Systems, Human Non-Coding Sequence Variants, and Blood Pressure.","authors":"Qiongzi Qiu,Mingyu Liang","doi":"10.1152/physrev.00029.2025","DOIUrl":"https://doi.org/10.1152/physrev.00029.2025","url":null,"abstract":"The human genome harbors millions of non-coding sequence variants. Genome-wide association studies (GWAS) have identified thousands of robust associations linking non-coding variants to human physiological traits and complex diseases. Integrative approaches, including expression quantitative trait locus mapping, epigenomic profiling, and precise genome editing in trait-relevant cell types, enable the identification of effector genes and underlying regulatory mechanisms, such as long-range chromatin interactions, that mediate the effects of non-coding variants. Investigations of blood pressure (BP)-associated non-coding sequence variants have uncovered previously unrecognized roles of genes in BP regulation, reinforced the human genetic relevance of established BP regulatory pathways, and elucidated specific regulatory mechanisms by which non-coding variants influence gene expression and BP. Studies of orthologous non-coding genomic regions in animal models corresponding to human genomic regions harboring BP-associated variants have demonstrated substantial effects on BP, suggesting that the phenotypic impact of non-coding sequence variants may be large within human subgroups. Continued expansion of functional studies of trait-associated non-coding sequence variants, together with advances in mapping molecular quantitative trait loci and epigenomic landscapes, will provide novel insights directly relevant to human biology and disease and essential for understanding humans as molecular systems.","PeriodicalId":20193,"journal":{"name":"Physiological reviews","volume":"82 1","pages":""},"PeriodicalIF":33.6,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146088909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-30DOI: 10.1152/physrev.00030.2025
Fabien D Legrand,Joanne Hudson,Ryan Rhodes
{"title":"Reversal Theory as a Complementary Perspective on Moment-to-Moment Variations in Motivation for Physical Activity.","authors":"Fabien D Legrand,Joanne Hudson,Ryan Rhodes","doi":"10.1152/physrev.00030.2025","DOIUrl":"https://doi.org/10.1152/physrev.00030.2025","url":null,"abstract":"","PeriodicalId":20193,"journal":{"name":"Physiological reviews","volume":"28 1","pages":""},"PeriodicalIF":33.6,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146073014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-24DOI: 10.1152/physrev.00011.2025
Jorge A Masso-Silva,Alexia Perryman,Sophia Karandashova,Avnee Jaya Kumar,Laura Barnes,Nikita Kasaraneni,Laura E Crotty Alexander
Although electronic cigarettes (e-cigarettes) have only been intensely studied since 2016, we have learned that the chemicals contained within e-cigarette aerosols (commonly called vapor) directly impact the function and phenotype of immune cells across the body (Graphical Abstract). This review focuses on white blood cells (leukocytes) as well as immune functions of epithelial cells, which are critical for host defense. We also detail the modulation of inflammatory mediators in different compartments, such as saliva, blood and airways, by e-cigarette vaping. Data is summarized across in vivo animal models, in vitro and ex vivo exposures of human and mouse cells, and from human subjects, with an emphasis on human data. A multitude of changes in immune cells and inflammatory mediators in response to e-cigarette vapor exposure has been identified, and here we synthesize what is known and the likely effects on physiology across the body.
{"title":"Impact of e-cigarette vaping on the immune system across the body.","authors":"Jorge A Masso-Silva,Alexia Perryman,Sophia Karandashova,Avnee Jaya Kumar,Laura Barnes,Nikita Kasaraneni,Laura E Crotty Alexander","doi":"10.1152/physrev.00011.2025","DOIUrl":"https://doi.org/10.1152/physrev.00011.2025","url":null,"abstract":"Although electronic cigarettes (e-cigarettes) have only been intensely studied since 2016, we have learned that the chemicals contained within e-cigarette aerosols (commonly called vapor) directly impact the function and phenotype of immune cells across the body (Graphical Abstract). This review focuses on white blood cells (leukocytes) as well as immune functions of epithelial cells, which are critical for host defense. We also detail the modulation of inflammatory mediators in different compartments, such as saliva, blood and airways, by e-cigarette vaping. Data is summarized across in vivo animal models, in vitro and ex vivo exposures of human and mouse cells, and from human subjects, with an emphasis on human data. A multitude of changes in immune cells and inflammatory mediators in response to e-cigarette vapor exposure has been identified, and here we synthesize what is known and the likely effects on physiology across the body.","PeriodicalId":20193,"journal":{"name":"Physiological reviews","volume":"31 1","pages":""},"PeriodicalIF":33.6,"publicationDate":"2026-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146042472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-16DOI: 10.1152/physrev.00020.2025
Andreas A Boehmer,Sandro Ninni,Jordi Heijman,Dobromir Dobrev,Stanley Nattel
Atrial fibrillation (AF) is a major public health problem, associated with increased risks of heart failure, stroke, dementia, and mortality. The treatment of AF involves multiple potential approaches, all of which presently have significant limitations. Over the past 20 years, tremendous advances have been made in understanding the pathophysiological determinants of AF. The present narrative review article aims to address selected issues that are highly relevant to clinically important questions in AF pathophysiology, by reviewing insights from both experimental observations and complementary clinical investigations. Issues that we address include: 1) Introduction and mechanistic concepts; 2) The mechanistic basis for the crucial role of the pulmonary veins in AF; 3) The progressive natural history of AF; 4) The nature and mechanisms of secondary AF; 5) AF and heart failure with reduced ejection fraction; 6) AF and heart failure with preserved ejection fraction; 7) AF burden- importance and mechanistic determinants; and 8) The clinical importance of better understanding AF pathophysiology, leveraging new physiological knowledge and technologies to improve AF prevention. We consider in detail changes in ion channel and transporter function, the importance of inflammatory signaling, and the contribution of changes in tissue structure and composition in the development of AF-promoting atrial cardiomyopathy. The developments in our understanding of AF pathophysiology have been enormous and have produced many new conceptual and therapeutic opportunities, along with a wide range of important new questions. To capitalize on these opportunities and address the new questions that have emerged will require substantial additional investigation.
{"title":"The Clinical Pathophysiology of Atrial Fibrillation - Outstanding Questions from Bedside to Bench and Back.","authors":"Andreas A Boehmer,Sandro Ninni,Jordi Heijman,Dobromir Dobrev,Stanley Nattel","doi":"10.1152/physrev.00020.2025","DOIUrl":"https://doi.org/10.1152/physrev.00020.2025","url":null,"abstract":"Atrial fibrillation (AF) is a major public health problem, associated with increased risks of heart failure, stroke, dementia, and mortality. The treatment of AF involves multiple potential approaches, all of which presently have significant limitations. Over the past 20 years, tremendous advances have been made in understanding the pathophysiological determinants of AF. The present narrative review article aims to address selected issues that are highly relevant to clinically important questions in AF pathophysiology, by reviewing insights from both experimental observations and complementary clinical investigations. Issues that we address include: 1) Introduction and mechanistic concepts; 2) The mechanistic basis for the crucial role of the pulmonary veins in AF; 3) The progressive natural history of AF; 4) The nature and mechanisms of secondary AF; 5) AF and heart failure with reduced ejection fraction; 6) AF and heart failure with preserved ejection fraction; 7) AF burden- importance and mechanistic determinants; and 8) The clinical importance of better understanding AF pathophysiology, leveraging new physiological knowledge and technologies to improve AF prevention. We consider in detail changes in ion channel and transporter function, the importance of inflammatory signaling, and the contribution of changes in tissue structure and composition in the development of AF-promoting atrial cardiomyopathy. The developments in our understanding of AF pathophysiology have been enormous and have produced many new conceptual and therapeutic opportunities, along with a wide range of important new questions. To capitalize on these opportunities and address the new questions that have emerged will require substantial additional investigation.","PeriodicalId":20193,"journal":{"name":"Physiological reviews","volume":"177 1","pages":""},"PeriodicalIF":33.6,"publicationDate":"2026-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145986411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-12DOI: 10.1152/physrev.00017.2025
Tessa A C Garrud,Daniel M Collier,Jonathan H Jaggar
Vascular smooth muscle cells express several types of potassium (K+) channel which control physiological functions including contractility, migration, proliferation, and differentiation. Five primary classes of K+ channel are present in vascular smooth muscle cells: large-conductance Ca2+-activated BK), voltage-dependent K+ (KV), inward rectifier K+ (Kir), adenosine triphosphate (ATP)-sensitive K+ KATP), and two-pore-domain (tandem pore domain) K+ (K2P) channels. Vascular smooth muscle cells express specific sub-members, splice variants, and auxiliary subunits of these five K+ channel classes to customize their properties. Expression patterns of K+ channels in smooth muscle cells can vary depending on vessel type, size, and anatomical origin. The expression, activity, trafficking, and surface abundance of K+ channels can be regulated by a wide variety of stimuli, including membrane voltage, ions, molecules, lipids, and proteins, including those generated by signal transduction pathways. K+ channel function can exhibit sexual dimorphism, change in conditions such as pregnancy aging, and alter in different diseases, including systemic and pulmonary hypertension, diabetes mellitus/metabolic syndrome, and brain disorders. Genetic mutations in genes which encode K+ channels are also associated with pathological alterations in vascular smooth muscle function. Here, provide a comprehensive summary of approximately 40 years of literature investigating the expression, regulation, function, and pathological modification of BK, KV, Kir, KATP, and K2P channels in vascular smooth muscle cells.
{"title":"Potassium channels in vascular smooth muscle cells.","authors":"Tessa A C Garrud,Daniel M Collier,Jonathan H Jaggar","doi":"10.1152/physrev.00017.2025","DOIUrl":"https://doi.org/10.1152/physrev.00017.2025","url":null,"abstract":"Vascular smooth muscle cells express several types of potassium (K+) channel which control physiological functions including contractility, migration, proliferation, and differentiation. Five primary classes of K+ channel are present in vascular smooth muscle cells: large-conductance Ca2+-activated BK), voltage-dependent K+ (KV), inward rectifier K+ (Kir), adenosine triphosphate (ATP)-sensitive K+ KATP), and two-pore-domain (tandem pore domain) K+ (K2P) channels. Vascular smooth muscle cells express specific sub-members, splice variants, and auxiliary subunits of these five K+ channel classes to customize their properties. Expression patterns of K+ channels in smooth muscle cells can vary depending on vessel type, size, and anatomical origin. The expression, activity, trafficking, and surface abundance of K+ channels can be regulated by a wide variety of stimuli, including membrane voltage, ions, molecules, lipids, and proteins, including those generated by signal transduction pathways. K+ channel function can exhibit sexual dimorphism, change in conditions such as pregnancy aging, and alter in different diseases, including systemic and pulmonary hypertension, diabetes mellitus/metabolic syndrome, and brain disorders. Genetic mutations in genes which encode K+ channels are also associated with pathological alterations in vascular smooth muscle function. Here, provide a comprehensive summary of approximately 40 years of literature investigating the expression, regulation, function, and pathological modification of BK, KV, Kir, KATP, and K2P channels in vascular smooth muscle cells.","PeriodicalId":20193,"journal":{"name":"Physiological reviews","volume":"81 1","pages":""},"PeriodicalIF":33.6,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145956127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-07DOI: 10.1152/physrev.00015.2025
Steven A Shea, Frank A J L Scheer, Michelle L Gumz, Sophia Eikenberry, Jingyi Qian, Saurabh S Thosar, Michael J Sole, Tami A Martino
Circadian rhythms, governed by the body's endogenous clock mechanism, regulate daily fluctuations in cardiovascular function, optimizing physiological processes like blood pressure regulation, cardiac metabolism, and myocardial repair. Rhythms also align cardiovascular reactivity with predictable environmental and behavioral cycles, enabling normal function and affecting disease susceptibility. Major adverse cardiovascular events, including myocardial infarction, ventricular arrhythmias, and stroke, exhibit a distinct morning peak, highlighting circadian regulation in cardiovascular health. Controlled human laboratory studies demonstrate that beyond the influences of sleep and other behaviors, endogenous circadian rhythms independently regulate blood pressure, autonomic nervous system activity, blood clotting, vascular tone, and metabolic function. Additionally, the kidney plays a critical role in circadian sodium handling, fluid balance, and blood pressure control, with disruptions in renal circadian rhythms contributing to hypertension and progression to heart failure. Chronic circadian misalignment resulting from shift work, irregular sleep-wake cycles, or misaligned lifestyle habits is strongly associated with increased cardiovascular risk and disease progression. The emerging field of Circadian Medicine applies circadian principles to clinical care, leveraging interventions such as optimizing light exposure, meal timing, and physical activity to restore biological alignment. Chronotherapy, the strategic timing of medications or procedures to align with a patient's diurnal or circadian rhythms, offers further potential for enhancing treatments and reducing adverse effects. By integrating circadian biology into cardiovascular medicine, novel strategies are emerging to help prevent disease, improve patient outcomes, and enhance therapeutic precision. Understanding the interplay between circadian regulation and cardiovascular physiology provides a foundation for advancing cardiovascular prevention and treatment strategies.
{"title":"Unlocking the Potential of Circadian Biology for Cardiovascular Health.","authors":"Steven A Shea, Frank A J L Scheer, Michelle L Gumz, Sophia Eikenberry, Jingyi Qian, Saurabh S Thosar, Michael J Sole, Tami A Martino","doi":"10.1152/physrev.00015.2025","DOIUrl":"10.1152/physrev.00015.2025","url":null,"abstract":"<p><p>Circadian rhythms, governed by the body's endogenous clock mechanism, regulate daily fluctuations in cardiovascular function, optimizing physiological processes like blood pressure regulation, cardiac metabolism, and myocardial repair. Rhythms also align cardiovascular reactivity with predictable environmental and behavioral cycles, enabling normal function and affecting disease susceptibility. Major adverse cardiovascular events, including myocardial infarction, ventricular arrhythmias, and stroke, exhibit a distinct morning peak, highlighting circadian regulation in cardiovascular health. Controlled human laboratory studies demonstrate that beyond the influences of sleep and other behaviors, endogenous circadian rhythms independently regulate blood pressure, autonomic nervous system activity, blood clotting, vascular tone, and metabolic function. Additionally, the kidney plays a critical role in circadian sodium handling, fluid balance, and blood pressure control, with disruptions in renal circadian rhythms contributing to hypertension and progression to heart failure. Chronic circadian misalignment resulting from shift work, irregular sleep-wake cycles, or misaligned lifestyle habits is strongly associated with increased cardiovascular risk and disease progression. The emerging field of Circadian Medicine applies circadian principles to clinical care, leveraging interventions such as optimizing light exposure, meal timing, and physical activity to restore biological alignment. Chronotherapy, the strategic timing of medications or procedures to align with a patient's diurnal or circadian rhythms, offers further potential for enhancing treatments and reducing adverse effects. By integrating circadian biology into cardiovascular medicine, novel strategies are emerging to help prevent disease, improve patient outcomes, and enhance therapeutic precision. Understanding the interplay between circadian regulation and cardiovascular physiology provides a foundation for advancing cardiovascular prevention and treatment strategies.</p>","PeriodicalId":20193,"journal":{"name":"Physiological reviews","volume":" ","pages":""},"PeriodicalIF":28.7,"publicationDate":"2026-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12882775/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145918285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-29DOI: 10.1152/physrev.00049.2024
Marija Glisic,Adea Llane,Stevan Stojic,Erand Llanaj,Zayne Milena Roa-Díaz,Peter Francis Raguindin,Lum Kastrati,Lara Weed,Mintu P Turakhia,Euan Ashley,Taulant Muka,John P A Ioannidis
We conducted an umbrella review to synthesize the evidence on the effectiveness of interventions incorporating wrist-worn wearables* feedback on diverse health outcomes including health promotion (i.e., health behaviors and disease risk perception) morbidity, mortality, functioning, and other health-related metrics in humans. We searched in MEDLINE, Web of Science, Embase and Cochrane Library until 18th March 2025 for eligible systematic reviews. After screening 9 487 citations, we identified 39 systematic reviews, which included 98 original studies (one observational study, 95 randomized controlled trials, and two pre-post studies). The reviews primarily focused on adult populations, individuals with cardiometabolic conditions, and cancer survivors. The original interventional studies mainly included Fitbit (40.2%), Polar (12.4%), and ActiGraph (10.3%) devices. Over 80% of the clinical trials involved complex behavioral interventions with wearable-based feedback, and the control groups varied. Most systematic reviews were rated as low confidence, with common flaws including inadequate considerations for risk-of-bias and heterogeneity. Interventions incorporating wrist-worn activity trackers increased physical activity in diverse populations. The effect of interventions incorporating wrist-wearables' feedback on cardiometabolic risk markers, quality of life, depression/anxiety and pain was limited and remained inconsistent. Our findings rely on existing systematic reviews, which may vary in quality, review methodologies and comprehensiveness. There is also potential for missing more recent evidence not yet captured in these reviews. These limitations should be considered when interpreting our results. Acknowledging these caveats, wrist-worn wearables seem to increase physical activity, and may have also additional benefits that require further study.
我们进行了一项总括性综述,以综合有关干预措施有效性的证据,这些干预措施包括手腕可穿戴设备*对各种健康结果的反馈,包括人类健康促进(即健康行为和疾病风险感知)发病率、死亡率、功能和其他与健康相关的指标。我们在MEDLINE、Web of Science、Embase和Cochrane Library检索了符合条件的系统综述,检索截止日期为2025年3月18日。在筛选了9487篇引用后,我们确定了39篇系统综述,其中包括98项原始研究(1项观察性研究、95项随机对照试验和2项前后研究)。这些综述主要集中在成人人群、患有心脏代谢疾病的个体和癌症幸存者。最初的介入研究主要包括Fitbit(40.2%)、Polar(12.4%)和ActiGraph(10.3%)设备。超过80%的临床试验涉及复杂的行为干预和基于可穿戴设备的反馈,对照组各不相同。大多数系统评价被评为低置信度,常见的缺陷包括对偏倚风险和异质性考虑不足。结合手腕活动追踪器的干预措施增加了不同人群的身体活动。结合可穿戴腕带反馈的干预措施对心脏代谢风险指标、生活质量、抑郁/焦虑和疼痛的影响是有限的,并且仍然不一致。我们的研究结果依赖于现有的系统评价,这些评价在质量、评价方法和全面性上可能各不相同。在这些综述中还没有捕捉到的近期证据也有可能被遗漏。在解释我们的结果时应考虑到这些局限性。考虑到这些警告,腕戴式可穿戴设备似乎可以增加体力活动,而且可能还有其他好处,需要进一步研究。
{"title":"An umbrella review of systematic reviews of the impact of wrist-worn wearables on health outcomes.","authors":"Marija Glisic,Adea Llane,Stevan Stojic,Erand Llanaj,Zayne Milena Roa-Díaz,Peter Francis Raguindin,Lum Kastrati,Lara Weed,Mintu P Turakhia,Euan Ashley,Taulant Muka,John P A Ioannidis","doi":"10.1152/physrev.00049.2024","DOIUrl":"https://doi.org/10.1152/physrev.00049.2024","url":null,"abstract":"We conducted an umbrella review to synthesize the evidence on the effectiveness of interventions incorporating wrist-worn wearables* feedback on diverse health outcomes including health promotion (i.e., health behaviors and disease risk perception) morbidity, mortality, functioning, and other health-related metrics in humans. We searched in MEDLINE, Web of Science, Embase and Cochrane Library until 18th March 2025 for eligible systematic reviews. After screening 9 487 citations, we identified 39 systematic reviews, which included 98 original studies (one observational study, 95 randomized controlled trials, and two pre-post studies). The reviews primarily focused on adult populations, individuals with cardiometabolic conditions, and cancer survivors. The original interventional studies mainly included Fitbit (40.2%), Polar (12.4%), and ActiGraph (10.3%) devices. Over 80% of the clinical trials involved complex behavioral interventions with wearable-based feedback, and the control groups varied. Most systematic reviews were rated as low confidence, with common flaws including inadequate considerations for risk-of-bias and heterogeneity. Interventions incorporating wrist-worn activity trackers increased physical activity in diverse populations. The effect of interventions incorporating wrist-wearables' feedback on cardiometabolic risk markers, quality of life, depression/anxiety and pain was limited and remained inconsistent. Our findings rely on existing systematic reviews, which may vary in quality, review methodologies and comprehensiveness. There is also potential for missing more recent evidence not yet captured in these reviews. These limitations should be considered when interpreting our results. Acknowledging these caveats, wrist-worn wearables seem to increase physical activity, and may have also additional benefits that require further study.","PeriodicalId":20193,"journal":{"name":"Physiological reviews","volume":"15 1","pages":""},"PeriodicalIF":33.6,"publicationDate":"2025-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145847527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-23DOI: 10.1152/physrev.00010.2025
Kirsteen N Browning,R Alberto Travagli,Carolina Pellegrini
Thanks to its extensive intrinsic (enteric) neural networks spanning its entire length, the gastrointestinal (GI) tract has long been recognized for its ability to operate independently of the central nervous system (CNS). Despite that, the CNS provides both sympathetic and parasympathetic inputs to the GI tract, that confers an additional layer of regulation, modulation, and integration over GI functions. The sympathetic nervous system provides neurovascular control of GI blood flow in addition to its effects to decrease mucosal secretion, regulate sphincter tone, and modulate motility, principally via prejunctional and presynaptic actions. The parasympathetic nervous system, however, exerts both excitatory and inhibitory effects; the extent to which this influences gut functions varies throughout the length of the GI tract. Recent studies have also demonstrated that, in addition to regulation via the autonomic nervous system, 'higher' CNS nuclei also provide a significant degree of influence over GI functions under both physiological and pathophysiological conditions In addition to describing the anatomical neurocircuits and physiological functions of the extrinsic inputs to the GI tract, this review will also discuss the roles of brainstem, midbrain, and cortical nuclei that influence the gut within the context of relevant physiological and pathophysiological conditions.
{"title":"Central Control of Gastrointestinal Functions in Health and Disease.","authors":"Kirsteen N Browning,R Alberto Travagli,Carolina Pellegrini","doi":"10.1152/physrev.00010.2025","DOIUrl":"https://doi.org/10.1152/physrev.00010.2025","url":null,"abstract":"Thanks to its extensive intrinsic (enteric) neural networks spanning its entire length, the gastrointestinal (GI) tract has long been recognized for its ability to operate independently of the central nervous system (CNS). Despite that, the CNS provides both sympathetic and parasympathetic inputs to the GI tract, that confers an additional layer of regulation, modulation, and integration over GI functions. The sympathetic nervous system provides neurovascular control of GI blood flow in addition to its effects to decrease mucosal secretion, regulate sphincter tone, and modulate motility, principally via prejunctional and presynaptic actions. The parasympathetic nervous system, however, exerts both excitatory and inhibitory effects; the extent to which this influences gut functions varies throughout the length of the GI tract. Recent studies have also demonstrated that, in addition to regulation via the autonomic nervous system, 'higher' CNS nuclei also provide a significant degree of influence over GI functions under both physiological and pathophysiological conditions In addition to describing the anatomical neurocircuits and physiological functions of the extrinsic inputs to the GI tract, this review will also discuss the roles of brainstem, midbrain, and cortical nuclei that influence the gut within the context of relevant physiological and pathophysiological conditions.","PeriodicalId":20193,"journal":{"name":"Physiological reviews","volume":"3 1","pages":""},"PeriodicalIF":33.6,"publicationDate":"2025-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145807930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-22DOI: 10.1152/physrev.00012.2025
Ada Gjyrezi,Charalampos Skarlis,Clio Mavragani,Paraskevi Giannakakou
Autoimmune diseases arise from an aberrant immune response against self-antigens, whereas cancer often develops when the immune system fails to effectively detect and destroy malignant cells. Although historically viewed as distinct entities with opposing immune mechanisms, recent findings highlight significant overlaps in their immunological pathways. This review explores the intricate interplay between autoimmunity and cancer, focusing on immune surveillance, checkpoint regulation, cytokine signaling, and genetic susceptibility. In addition, we discuss epidemiological links, including the heightened risk of malignancy in patients with autoimmune disorders and the autoimmune manifestations often triggered by cancer immunotherapies. We place particular emphasis on shared molecular signatures, predictive biomarkers, and the bidirectional immune modulation that arises from checkpoint inhibitors and biologic agents. Finally, we address the major clinical challenges in managing patients who present with both conditions and propose future research directions aimed at refining immunotherapeutic strategies.
{"title":"Crossroads between autoimmunity and cancer: Underlying mechanisms and clinical implications.","authors":"Ada Gjyrezi,Charalampos Skarlis,Clio Mavragani,Paraskevi Giannakakou","doi":"10.1152/physrev.00012.2025","DOIUrl":"https://doi.org/10.1152/physrev.00012.2025","url":null,"abstract":"Autoimmune diseases arise from an aberrant immune response against self-antigens, whereas cancer often develops when the immune system fails to effectively detect and destroy malignant cells. Although historically viewed as distinct entities with opposing immune mechanisms, recent findings highlight significant overlaps in their immunological pathways. This review explores the intricate interplay between autoimmunity and cancer, focusing on immune surveillance, checkpoint regulation, cytokine signaling, and genetic susceptibility. In addition, we discuss epidemiological links, including the heightened risk of malignancy in patients with autoimmune disorders and the autoimmune manifestations often triggered by cancer immunotherapies. We place particular emphasis on shared molecular signatures, predictive biomarkers, and the bidirectional immune modulation that arises from checkpoint inhibitors and biologic agents. Finally, we address the major clinical challenges in managing patients who present with both conditions and propose future research directions aimed at refining immunotherapeutic strategies.","PeriodicalId":20193,"journal":{"name":"Physiological reviews","volume":"21 1","pages":""},"PeriodicalIF":33.6,"publicationDate":"2025-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145801011","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}